OrganiGram Holdings Inc.
NASDAQ:OGI
1.56 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 159.841 | 149.205 | 145.809 | 79.163 | 86.795 | 80.413 | 12.429 | 5.714 | 6.128 | 0.987 | 0 | 0 | 0 |
| Cost of Revenue
| 112.317 | 114.132 | 114.24 | 107.562 | 143.285 | 31.944 | 39.204 | 8.841 | 0.813 | 0.34 | 0.275 | 0 | 0 |
| Gross Profit
| 47.524 | 35.073 | 31.569 | -28.399 | -56.49 | 48.469 | -26.775 | -3.127 | 5.314 | 0.647 | -0.275 | 0 | 0 |
| Gross Profit Ratio
| 0.297 | 0.235 | 0.217 | -0.359 | -0.651 | 0.603 | -2.154 | -0.547 | 0.867 | 0.656 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 11.2 | 12.186 | 5.962 | 3.45 | 1.269 | 0.409 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 48.293 | 48.951 | 42.354 | 30.717 | 29.942 | 26.671 | 9.271 | 4.776 | 2.311 | 1.764 | 0.067 | 0.319 | 0.14 |
| Selling & Marketing Expenses
| 19.851 | 17.86 | 16.86 | 15.807 | 16.528 | 14.625 | 6.303 | 2.847 | 1.758 | 0.721 | 0.181 | 0 | 0 |
| SG&A
| 68.144 | 71.678 | 59.214 | 46.524 | 46.47 | 41.296 | 15.574 | 7.623 | 4.069 | 2.485 | 0.067 | 0.319 | 0.14 |
| Other Expenses
| 3.851 | 0 | 5.145 | -5.534 | -6.373 | 0.664 | 0.509 | 0.416 | 0 | 0 | 0 | 0.056 | 0 |
| Operating Expenses
| 83.195 | 271.478 | 70.321 | 44.44 | 41.366 | 42.369 | 16.083 | 8.04 | 4.069 | 2.485 | 0.067 | 0.375 | 0.14 |
| Operating Income
| -35.671 | -48.79 | -38.752 | -91.82 | -145.51 | 5.487 | 36.416 | -11.167 | 1.246 | -1.159 | -0.067 | -0.375 | -0.14 |
| Operating Income Ratio
| -0.223 | -0.327 | -0.266 | -1.16 | -1.676 | 0.068 | 2.93 | -1.954 | 0.203 | -1.175 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -9.769 | -184.206 | 24.381 | -38.884 | -46.984 | -11.362 | -8.639 | 0.211 | -0.399 | -0.118 | 1.383 | 0 | 0 |
| Income Before Tax
| -45.44 | -232.997 | -14.371 | -130.704 | -146.628 | -5.875 | 27.777 | -10.89 | 0.847 | -1.277 | -0.239 | -0.375 | 0 |
| Income Before Tax Ratio
| -0.284 | -1.562 | -0.099 | -1.651 | -1.689 | -0.073 | 2.235 | -1.906 | 0.138 | -1.294 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 3.519 | -0.088 | 1.842 | -10.471 | 3.629 | 5.653 | -0.551 | -0.037 | 0.002 | 0.172 | 0 | 0.14 |
| Net Income
| -45.44 | -229.478 | -14.283 | -132.546 | -136.157 | -9.504 | 20.513 | -10.89 | 0.847 | -1.277 | -0.239 | -0.375 | -0.14 |
| Net Income Ratio
| -0.284 | -1.538 | -0.098 | -1.674 | -1.569 | -0.118 | 1.65 | -1.906 | 0.138 | -1.294 | 0 | 0 | 0 |
| EPS
| -0.44 | -2.82 | -0.18 | -2.07 | -3.15 | -0.27 | 0.68 | -0.45 | 0.058 | -0.098 | -0.12 | -0.18 | -0.08 |
| EPS Diluted
| -0.42 | -2.82 | -0.18 | -2.07 | -3.15 | -0.27 | 0.65 | -0.45 | 0.058 | -0.098 | -0.12 | -0.18 | -0.08 |
| EBITDA
| -23.592 | -25.365 | -15.209 | -42.924 | -122.662 | 12.695 | 41.399 | -9.616 | 2.031 | -0.747 | 0.107 | -0.375 | -0.14 |
| EBITDA Ratio
| -0.148 | -0.17 | -0.104 | -0.542 | -0.934 | 0.171 | 3.214 | -1.683 | 0.331 | -0.754 | 0 | 0 | 0 |